Biomesense
Chicago, US · Founded 2018 · Delaware corporation · 17 employees on LinkedIn · 6 known investors
BiomeSense builds an AI-enabled platform combining hardware (GutLab) and bioinformatics (MetaBiome) to continuously generate and analyze gut microbiome data. It serves scientists, institutions, and companies conducting clinical research on the microbiome for personalized biomarker discovery and product development.
Founders & leadership
KH
Kevin HonakerinCEO
Board
DN
Dylan NicholsinTechnical Operations Lead
AH
VR
Vanessa Rollings GiannisBoard director
AB
OE
Orhan ErtughrulBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$15.7M disclosed across 3 rounds · 2019–2025
▶$7.1MraisedNov 2025 · 27 investors · BiotechnologyRule 506(b)
▶$7.1MraisedNov 2025 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dylan NicholsDirector
- Ashley HartmanDirector
- Kevin HonakerExecutive Officer, Director
- Vanessa Rollings GiannisDirector
- Andrew BluesteinDirector
- Offering amount
- $7.3M
- Amount sold
- $7.1M
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.2MraisedDec 2023 · 33 investors · BiotechnologyRule 506(b)
▶$6.2MraisedDec 2023 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dylan NicholsDirector
- Parikshit SharmaDirector
- Vanessa Rollings GiannisDirector
- Kevin HonakerExecutive Officer, Director
- Andrew BluesteinDirector
- Offering amount
- $6.5M
- Amount sold
- $6.2M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4MraisedOct 2019 · 5 investors · BiotechnologyRule 506(b)
▶$2.4MraisedOct 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin HonakerExecutive Officer, Director
- Dylan NicholsDirector
- Orhan ErtughrulDirector
- Offering amount
- $2.5M
- Amount sold
- $2.4M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapBiome13 shared keywordsBiome makes Taiga, a smart hydroponic living wall with onboard sensors, automated irrigation, and lighting that automates indoor plant care, along with the Halo grow light, plant supplements, and a companion app to monitor and control the system. It sells soil-free, fully grown living walls for home consumers, shipped from its indoor vertical greenhouse in Oakland, CA.
Biome Analytics12 shared keywordsBiome provides analytics tools for healthcare leaders, focused on improving cardiovascular care outcomes and reducing operational inefficiency. It serves hospitals and cardiac care centers, offering data-driven products including the Biome Performance Network for clinical and operational decision-making.
Viome10 shared keywordsViome offers at-home tests that analyze the gut and oral microbiome plus cellular blood samples using mRNA/metatranscriptomic sequencing, returning 70+ health scores (including biological age and inflammation) and personalized food and supplement recommendations. The direct-to-consumer service, analyzed in a CLIA-certified lab, is aimed at individuals seeking insights into digestion, metabolism, and overall wellness.
Agbiome9 shared keywordsUS agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.
BIOHM8 shared keywordsBIOHM sells probiotic supplements and at-home gut test kits that analyze the microbiome, with results reviewed by a microbiome-trained registered nutritionist who provides personalized diet and supplement recommendations. Its formula combines bacteria, fungi, and a digestive enzyme intended to support digestive health.
Companies competing with Biomesense for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Biomesense do?
- BiomeSense builds an AI-enabled platform combining hardware (GutLab) and bioinformatics (MetaBiome) to continuously generate and analyze gut microbiome data. It serves scientists, institutions, and companies conducting clinical research on the microbiome for personalized biomarker discovery and product development.
- Who are Biomesense's investors?
- Biomesense's investors include Bluestein Ventures, Chicago Early Growth Ventures (CEGV), ECP Growth, IrishAngels, Overton Venture Capital, Service Provider Capital.
- How much funding has Biomesense raised?
- Biomesense has disclosed $15.7M raised across 3 rounds.
- Where is Biomesense headquartered?
- Biomesense is headquartered in Chicago, US.